[Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine]
about
Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skinSynthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinasesCharacterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cellsPlatelet-activating factor: receptors and signal transductionRole of platelet-activating factor in the pathogenesis of acute pancreatitis.Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesisMetabolism of platelet-activating factor in isolated perfused rat lungCharacterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic childrenPlatelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils.Platelet-activating factor relaxes ferret tracheal smooth muscle and reduces transepithelial potential difference in vitro.Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor.Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma.Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factorRelease of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids.Release of a slow-reacting substance from rabbit platelets.Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation.Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.Presence of paf-acether in rheumatic diseases.Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730.Metabolism of platelet-activating factor in human haematopoietic cell lines. Differences between myeloid and lymphoid cells.Anaphylactic actions of platelet-activating factor.Emerging roles of PAR-1 and PAFR in melanoma metastasis.Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.Inflammatory exudates in skin windows induced by 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine.Paf-acether synthesis by Helicobacter pylori.Phospholipid biosynthesis in human platelets. The acylation of lyso-platelet-activating factor.Arachidonyl transfer from diacyl phosphatidylcholine to ether phospholipids in rat platelets.Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparationsThe role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine.1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants.Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked.The role of lipids in the inception, maintenance and complications of dengue virus infectionRelease of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils
P2860
Q24672250-AEC105C7-C4E7-4E32-B4EA-A666251C0CCFQ24682349-DDC4D9D9-CBDF-4DC6-987A-9F947BD3E33CQ28219806-6649B6F7-50F2-4517-A2A0-BEF18FBECF1EQ28609556-ABA099DB-57C2-43FE-9481-6D73D9A5D99FQ33788285-5CCF0FFF-FF9A-4390-8589-B60F24D71267Q34557708-7929F8AE-FAC7-4622-BE49-19D9ABD946EFQ34576825-8727849B-3CD3-4806-91C5-6B0958CF2892Q35594599-37ABC2D7-1C0A-4A84-B8F2-45E2FE7AF1A8Q35755005-DC97C9E3-E6A7-4AE9-99C5-BA62AAD330F6Q35872339-950BCFAD-F8A2-49F5-837C-7F4D68C8CA49Q35885820-7364E0F5-E60A-4E04-9C15-534975A7414AQ35915423-BD015BA9-BD14-41E5-B5B7-3A9429BF1503Q36357510-5F8DC3FA-7D91-4874-8753-B90EC7D34ABDQ36417714-D0D3986B-FFE2-4366-9C80-9CEF8A5B2425Q37006790-1CCE1F5E-B2CB-486B-BB63-65D692876429Q37485044-59C35C4B-1CE5-4694-86CF-6DDAC75ACC4DQ37676256-57AE41B3-72AC-4598-AE35-67FA25C07D32Q37819332-DF072101-F5E1-4DA0-A605-0CE4892B1871Q39208689-27D9E0D2-735C-44B2-B9FF-AC885BB3CF70Q41243890-B929F114-86F7-4E7C-B8F5-3FCB6495442DQ41283762-E2D20D26-8AB5-46C9-A367-572628084D17Q41697703-2FE3BA32-27D9-4253-91D8-5F41ABD643C0Q41810357-2044F0B5-06C6-47D6-BB16-D1BB6ED70F6FQ41904115-0520C1B8-5450-450C-972A-EFF038A305A7Q41906314-2BFBAA6A-CA1A-490C-B3CB-1BD1F98E985FQ41925715-57142E34-6C5D-421E-9918-809A56058887Q41986677-0EC1E999-C29F-4342-8DD9-8232122C2283Q42000579-4420DF98-909A-4D3F-A5EC-E619B1ACFD1DQ42089701-99DA0247-EF29-4FEC-932C-EBCEC2546683Q42226119-BE5DAEC5-B2D9-47E6-A0B8-A914ADAE503BQ42636200-51C1C40B-B5B9-4692-BC02-5177B4FFDA45Q42710783-9C26E39E-C0CB-4F1F-8061-3DC5AD1D38D2Q42716182-409045D9-A2EC-4115-B46A-B7A89765182BQ42735280-25BC5159-EA53-490E-B9ED-2427AF68BDFCQ42735338-88BCA27B-3CB2-4605-B08B-F5FACD6CEE71Q42848383-200A79D7-FEBE-4BB2-9AB9-FE8849CF722FQ42850005-D34B1BA8-B6DE-4144-8805-E3C1BE415886Q56378131-3709EC35-8D29-4D4F-B246-E1869919D0DFQ58831974-104B0C7A-20DF-478F-A785-FDB34856DE91
P2860
[Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine]
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
[Semi-synthesis and proposed s ...... og of lysophosphatidylcholine]
@en
[Semi-synthesis and proposed structure of platelet-activating factor
@nl
type
label
[Semi-synthesis and proposed s ...... og of lysophosphatidylcholine]
@en
[Semi-synthesis and proposed structure of platelet-activating factor
@nl
prefLabel
[Semi-synthesis and proposed s ...... og of lysophosphatidylcholine]
@en
[Semi-synthesis and proposed structure of platelet-activating factor
@nl
P2093
P1476
[Semi-synthesis and proposed s ...... og of lysophosphatidylcholine]
@en
P2093
P304
P577
1979-11-01T00:00:00Z